John Evans, Author at PEGUS Research

We are a unique, full-service OTC consumer behavior research organization. We specialize in the label comprehension, self-selection, and actual use studies that lead to successful OTC approval. We provide expert, end-to-end support for Drug Facts Label development and testing, including consulting, support for FDA interactions, protocol design, study conduct, site selection and management, monitoring, data management, statistics, medical writing and submission-ready data (CDISC) services.

View our Website Privacy Policy & Study Privacy Notice

John Evans

Application for First OTC Birth Control Pill in the US

PEGUS Research Embraces and Expands WFH Model

RWE Study Conducted by PEGUS Research Published in Contraception

Sterling IRB Features Pegus Research in Whitepaper Article Titled “PPC and Social Media Patient Recruitment: Strategies for Success”

MHRA Approves Nuromol (Combined Paracetamol and Ibuprofen) for General Sale in UK

FDA Approves “First-in-Class” Nasal Antihistamine (Astepro Allergy) For OTC

Clark Richardson Participates in June 2021 FDA Public Workshop on the OTC Drug Facts Label

PEGUS Announces Even More Enhancements to Its “Decentralized” Research Model

Brandon Henrie Promoted to Vice President – Finance and Strategy

FDA Approves New Combination Pain Reliever (Advil Dual Action) for OTC

About Us

Recent News

Quick Links